News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| HHLR ADVISORS, LTD. (10% Owner) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 611,000 shares
@ $211.4522, valued at
$129.2M
Sold 313,400 shares
@ $128.4335, valued at
$40.3M
Sold 273,728 shares
@ $207.7171, valued at
$56.9M
|
|
| 06/12/2023 |
4
| HHLR ADVISORS, LTD. (10% Owner) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 1,163,825 shares
@ $218.1443, valued at
$253.9M
Sold 213,700 shares
@ $130.3523, valued at
$27.9M
Sold 328,952 shares
@ $217.0183, valued at
$71.4M
Sold 281,400 shares
@ $130.8322, valued at
$36.8M
Sold 968,812 shares
@ $213.9125, valued at
$207.2M
|
|
| 08/24/2022 |
4
| HHLR ADVISORS, LTD. (10% Owner) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Acquired 7,800 shares
@ $0 |
|
| 10/27/2021 |
4
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. (10% Owner) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 647,862 shares
@ $15.895, valued at
$10.3M
|
|
| 11/15/2017 |
4
| Hillhouse Capital Management, Ltd. (10% Owner) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Converted 2,098,581 shares
@ $0
Bought 1,428,571 shares
@ $14, valued at
$20M
Converted 4,476,275 convertible preferred
@ $0 |
|
| 02/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|